For research use only. Not for therapeutic Use.
H-Arg-Lys-OH TFA is a dipeptide formed from L-arginyl and L-lysine residues[1].
To date only a few physiologically relevant advanced glycation end products (AGEs) have been characterised from tissues ex vivo, most notably lysine-lysine and lysine-arginine cross-link forming AGEs[1].
| Catalog Number | I046081 |
| Synonyms | (2S)-6-amino-2-[[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]hexanoic acid;2,2,2-trifluoroacetic acid |
| Molecular Formula | C14H27F3N6O5 |
| Purity | ≥95% |
| InChI | InChI=1S/C12H26N6O3.C2HF3O2/c13-6-2-1-5-9(11(20)21)18-10(19)8(14)4-3-7-17-12(15)16;3-2(4,5)1(6)7/h8-9H,1-7,13-14H2,(H,18,19)(H,20,21)(H4,15,16,17);(H,6,7)/t8-,9-;/m0./s1 |
| InChIKey | OPHRNGXTGITHQT-OZZZDHQUSA-N |
| SMILES | C(CCN)CC(C(=O)O)NC(=O)C(CCCN=C(N)N)N.C(=O)(C(F)(F)F)O |
| Reference | [1]. Collier TA, et al. Effect on the mechanical properties of type I collagen of intra-molecular lysine-arginine derived advanced glycation end-product cross-linking. J Biomech. 2018 Jan 23;67:55-61. |
